From: Burden of fatigue among adults living with HIV/AIDS attending antiretroviral therapy in Ethiopia
Variables | Frequency | % |
---|---|---|
CD4 counts | ||
< 200 cells/mm3 | 91 | 16.0 |
200–499 cells/mm3 | 308 | 54.4 |
> =500cells/mm3 | 168 | 29.6 |
WHO classification of HIV stage | ||
Stage I | 316 | 55.7 |
Stage II | 103 | 18.2 |
Stage III | 92 | 16.2 |
Stage IV | 56 | 9.9 |
Drug regimen | ||
AZT + 3TC + NVP | 115 | 20.3 |
AZT + 3TC + EFV | 41 | 7.2 |
TD3 + 3TC + EFV | 257 | 45.3 |
TDF + 3TC + NVP | 121 | 21.4 |
ABC + DDI + LPV/R | 33 | 5.8 |
Co-morbid health conditions | ||
No | 438 | 77.2 |
Yes | 129 | 22.8 |
Duration since HIV confirmed | ||
0–35 months | 235 | 41.4 |
≥ 36 | 332 | 58.6 |